A glaucoma drainage implant is a small device placed in the eye to treat glaucoma. There are many different ways to treat glaucoma. In addition to conventional and laser surgery, there are a variety of drugs to lower intraocular pressure (IOP). If these methods alone fail, doctors may suggest implants.

Researcher's newest research report, the “Glaucoma Aqueous Shunt Industry Forecast” looks at past sales and reviews total world Glaucoma Aqueous Shunt sales in 2022, providing a comprehensive analysis by region and market sector of projected Glaucoma Aqueous Shunt sales for 2023 through 2029. With Glaucoma Aqueous Shunt sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Glaucoma Aqueous Shunt industry.

This Insight Report provides a comprehensive analysis of the global Glaucoma Aqueous Shunt landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Glaucoma Aqueous Shunt portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Glaucoma Aqueous Shunt market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Glaucoma Aqueous Shunt and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Glaucoma Aqueous Shunt.

The global Glaucoma Aqueous Shunt market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Glaucoma Aqueous Shunt is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Glaucoma Aqueous Shunt is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Glaucoma Aqueous Shunt is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Glaucoma Aqueous Shunt players cover AbbVie, Santen Pharmaceutical, Johnson and Johnson, Advanced Ophthalmic Innovations (AOI), New World Medical, Glaukos Corp, Ocular Therapeutix and PolyActiva, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Glaucoma Aqueous Shunt market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type

Valved Drainage Implants

Non-valved Drainage Implants

Segmentation by application

Hospital

Ophthalmology Clinics

Ambulatory Surgery Centers

Others

This report also splits the market by region:

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

AbbVie

Santen Pharmaceutical

Johnson and Johnson

Advanced Ophthalmic Innovations (AOI)

New World Medical

Glaukos Corp

Ocular Therapeutix

PolyActiva

Key Questions Addressed in this Report

What is the 10-year outlook for the global Glaucoma Aqueous Shunt market?

What factors are driving Glaucoma Aqueous Shunt market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Glaucoma Aqueous Shunt market opportunities vary by end market size?

How does Glaucoma Aqueous Shunt break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?